Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Face Validity of the Kid's ITP Tools (KIT) in the Era of Thrombopoietin Receptor Agonists (TPO-RAs)

Catherine McGuire, Joel Livingston, Nancy Young, Vinita Dhir, Victor Blanchette, Melanie Kirby -Allen, Robert J Klaassen

Blood (2022) 140 (Supplement 1): 13152–13153.

https://doi.org/10.1182/blood-2022-169744

Published: 2022

Journal Articles

Pediatric Sickle Cell Disease: A Potential Role for the Complement System

Daniel Diatlov, Arlette Bohorquez, Melanie Jackson, Melina Cheong, Walter H.A. Kahr, Kevin H.M. Kuo, Melanie Kirby-Allen, Christoph Licht

Blood (2022) 140 (Supplement 1): 2517–2518.

https://doi.org/10.1182/blood-2022-167696

Published: 2022

Journal Articles

Evaluating the Impact of Thrombopoietin Receptor Agonists Medications on Patient Outcomes and Quality of Life in Pediatric Immune Thrombocytopenia

Joel Livingston, Melanie Jackson, Ziyad Alrajihi, Catherine McGuire, Robert J Klaassen, Melanie Kirby -Allen

Blood (2021) 138 (Supplement 1): 4072.

https://doi.org/10.1182/blood-2021-146031

Published: 2021

Journal Articles

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Ali Amid, MD, Rebecca Leroux, BScN, Manuela Merelles-Pulcini, MSc, Saeed Yassobi, MD, Antoine N Saliba, MD, Richard Ward, MSc, MRCP, FRCPath, Mehran Karimi, MD, Ali T. Taher, MD PhD, Robert J Klaassen, MD, Melanie Kirby-Allen, MD

Blood (2016) 128 (22): 3633.

https://doi.org/10.1182/blood.V128.22.3633.3633

Published: 2016

Journal Articles

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

Ali Amid, Shiyi Chen, William Brien, Melanie Kirby-Allen, Isaac Odame

Blood (2016) 127 (9): 1208–1211.

https://doi.org/10.1182/blood-2015-10-673889

Published: 2016

Includes: Supplemental data

Journal Articles

Bone Marrow Failure and Developmental Delay Caused By Mutations in Poly(A)-Specific Ribonuclease

Blood (2015) 126 (23): 2404.

https://doi.org/10.1182/blood.V126.23.2404.2404

Published: 2015

Journal Articles

Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β + -Thalassemia Phenotype

Ali Amid, MD, Barry Eng, BSc, Betty-Ann Hohenadel, BSc, Meredith Hanna, BSc, Lisa N. Nakamura, BSc, Lynda Walker, MLT, Melina Cheong, RN, BSc, Melanie Kirby-Allen, MBBS, John S. Waye, PhD

Blood (2014) 124 (21): 2692.

https://doi.org/10.1182/blood.V124.21.2692.2692

Published: 2014

Journal Articles

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure

Blood (2012) 119 (16): 3684–3690.

https://doi.org/10.1182/blood-2011-05-349621

Published: 2012

Journal Articles

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Jo Howard, MB, BChir, MRCP, FRCPath, Moira Malfroy, RN, Llewelyn Charlotte, PhD, Louise Choo, PhD, David Rees, FRCPath, Isabeau Walker, FRCA, Tony Johnson, PhD, Louise Tillyer, FRCPath, Karin Fijnvandraat, MD, PhD, Melanie Kirby-Allen, MD, Renate Hodge, MSc, Shilpi Purohit, Sally C. Davies, FRCP, FMedSci, Lorna M Williamson, FRCPath

Blood (2011) 118 (21): 9.

https://doi.org/10.1182/blood.V118.21.9.9

Published: 2011

Journal Articles

Comparing Patterns for Transitioning the Care of Young Adults with Sickle Cell Disease Versus Hemophilia: The Toronto Experience

Ewurabena Simpson, MD, MPH, Richard Ward, BSc, MRCP, FRCPath, Melanie Kirby, MD, Isaac Odame, MD

Blood (2011) 118 (21): 2072.

https://doi.org/10.1182/blood.V118.21.2072.2072

Published: 2011

Journal Articles

POST Marketing Observational Study of Children (6 years or older) Treated with Deferasirox (Exjade ICL 670)-One Year analysis

Nagina Parmar, PhD, Manroop Singh, BSc, Isaac Odame, MD, Melanie Kirby, MD

Blood (2011) 118 (21): 5295.

https://doi.org/10.1182/blood.V118.21.5295.5295

Published: 2011

Journal Articles

Renal Dysfunction in Thalassemia.

Charles T Quinn, MD, MS, Valerie L Johnson, MD, PhD, Hae-Young Kim, MS, DrPh, Felicia Trachtenberg, PhD, Maria G Vogiatzi, MD, Janet L Kwiatkowski, MD, MSCE, Ellis J Neufeld, MD, PhD, Ellen Fung, PhD, RD, Nancy F Olivieri, MD, Melanie Kirby-Allen, MD, Patricia J Giardina, MD

Blood (2009) 114 (22): 2008.

https://doi.org/10.1182/blood.V114.22.2008.2008

Published: 2009

Journal Articles

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Blood (2009) 114 (22): 262.

https://doi.org/10.1182/blood.V114.22.262.262

Published: 2009

Journal Articles

Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury

Blood (2009) 114 (21): 4632–4638.

https://doi.org/10.1182/blood-2009-02-203323

Published: 2009

Journal Articles

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Abdullah Kutlar, MD, Donald Brambilla, PhD, Betsy Clair, Anne Haghighat, Sule Bakanay, MD, Gaye Adams, MD, Ferdane Kutlar, MD, Virgil McKie, MD, Beatrice Files, MD, Gerald Woods, MD, Melanie Kirby, MD, Elliott Vichinsky, MD, Clark Brown, MD, Charles Scher, MD, Robert Adams, MD

Blood (2007) 110 (11): 429.

https://doi.org/10.1182/blood.V110.11.429.429

Published: 2007

Journal Articles

Constitutive Activation of Hemostasis in Children with Sickle Cell Disease.

MacGregor Steele, MD, Suzan Williams, MD, Fred Pluthero, PhD, K.W. Annie Bang, Ran Goldman, MD, Jeremy Friedman, MD, John Freedman, MD, Melanie Kirby, MD, Margaret L. Rand, PhD, Victor S. Blanchette, FRCP, Walter H. Kahr, MD,PhD

Blood (2006) 108 (11): 1216.

https://doi.org/10.1182/blood.V108.11.1216.1216

Published: 2006

Journal Articles

Vertebral Abnormalities by Spine Morphometry in Thalassemia.

Maria Vogiatzi, Eric Macklin, Robert Schneider, Joseph Lane, Irina Chaikodinov, Nancy Olivieri, Melanie Kirby, Elliott Vichinky, Ellen Fung, Janet Kwiatkowski, Melody Cunningham, Patricia Giardina

Blood (2006) 108 (11): 3829.

https://doi.org/10.1182/blood.V108.11.3829.3829

Published: 2006

Journal Articles

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Tom Adamkiewicz, MD, Miguel R. Abboud, MD, Julio C. Barredo, MD, Melanie Kirby-Allen, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Rathi V. Iyer, MD, Virgil McKie, MD, Gerald Milton Woods, MD, Abdullah Kutlar, MD, Carole Paley, MD, Jessica Peterson, Elizabeth Rackoff, Manuela Merelles-Pulcini, Elizabeth Dackiw, Kristin Stegenga, Nadine Odo, Mimi Lou, Robert J. Adams, MD

Blood (2006) 108 (11): 791.

https://doi.org/10.1182/blood.V108.11.791.791

Published: 2006

Journal Articles

High Prevalence of Fractures and Bone Pain in Thalassemia: The Thalassemia Clinical Research Network Experience.

Maria Vogiatzi, MD, Eric Macklin, PhD, Robert Schneider, MD, Joseph Lane, MD, Nancy Olivieri, MD, Melanie Kirby, MD, Angela Cheung, MD, Elliott Vichinsky, MD, Ellen Fung, PhD, Alan Cohen, MD, Janet Kwiatkowski, MD, Virginia Stallings, MD, Ingrid Holm, MD, Ellis Neufeld, MD, Patricia J. Giardina, MD

Blood (2005) 106 (11): 2706.

https://doi.org/10.1182/blood.V106.11.2706.2706

Published: 2005

Journal Articles

Low Bone Mass in Thalassemia: The Thalassemia Clinical Research Network (TCRN) Experience.

Maria G. Vogiatzi, MD, Joseph Lane, MD, Martin Fleisher, MD, Eric A. Macklin, PhD, Ellen B. Fung, PhD, Melanie Kirby, MD, Janet Kwiatkowski, MD, Ingrid Holm, MD, Nancy Olivieri, MD, Elliott Vichinsky, MD, Patricia J. Giardina, MD

Blood (2004) 104 (11): 3613.

https://doi.org/10.1182/blood.V104.11.3613.3613

Published: 2004

NARROW

Face Validity of the Kid's ITP Tools (KIT) in the Era of Thrombopoietin Receptor Agonists (TPO-RAs)

Pediatric Sickle Cell Disease: A Potential Role for the Complement System

Evaluating the Impact of Thrombopoietin Receptor Agonists Medications on Patient Outcomes and Quality of Life in Pediatric Immune Thrombocytopenia

Factors Impacting Quality of Life in Thalassemia Patients; Results from the Intercontinenthal Collaborative Study

Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

Bone Marrow Failure and Developmental Delay Caused By Mutations in Poly(A)-Specific Ribonuclease

Compound Heterozygosity for Hb S and a Novel Deletion of Dnase I Hypersensitivity Sites HS3 and HS4 of β-Globin Locus Control Region Results in Hb S/β + -Thalassemia Phenotype

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure

Pre-Operative Transfusion Reduces Serious Adverse Events in Patients with Sickle Cell Disease (SCD): Results From the Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) Randomised Controlled Multicentre Clinical Trial

Comparing Patterns for Transitioning the Care of Young Adults with Sickle Cell Disease Versus Hemophilia: The Toronto Experience

POST Marketing Observational Study of Children (6 years or older) Treated with Deferasirox (Exjade ICL 670)-One Year analysis

Renal Dysfunction in Thalassemia.

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury

Candidate Gene Polymorphisms and Their Association with TCD Velocities in Children with Sickle Cell Disease.

Constitutive Activation of Hemostasis in Children with Sickle Cell Disease.

Vertebral Abnormalities by Spine Morphometry in Thalassemia.

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

High Prevalence of Fractures and Bone Pain in Thalassemia: The Thalassemia Clinical Research Network Experience.

Low Bone Mass in Thalassemia: The Thalassemia Clinical Research Network (TCRN) Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only